Efficacy of Different Number of XELOX or SOX Chemotherapy Cycles After D2 Resection for Stage III Gastric Cancer
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Gastric Cancer"
DOI: 10.5230/jgc.2022.22.e11
Abstract: Purpose We aimed to explore whether the prognosis of patients treated with capecitabine and oxaliplatin (XELOX) or S-1 and oxaliplatin (SOX) regimens who received fewer cycles of chemotherapy after D2 radical resection for gastric cancer… read more here.
Keywords: gastric cancer; patients received; received cycles; cycles chemotherapy ... See more keywords